Key FInancial Inc - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 45 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Key FInancial Inc ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,562
+291.1%
7,5000.0%0.00%
+200.0%
Q2 2023$2,445
-24.2%
7,5000.0%0.00%0.0%
Q1 2023$3,225
-41.3%
7,5000.0%0.00%
-66.7%
Q4 2022$5,490
+9.8%
7,5000.0%0.00%
+50.0%
Q3 2022$5,000
-44.4%
7,5000.0%0.00%
-60.0%
Q2 2022$9,0007,5000.01%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders